Encompass Health Corporation Financial Ratios — HSOA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	78.97	95.22	52.75	33.47	36.75	28.71	24.07	27.29	19.33	23.56	16.82	23.8	24.54	25.14
Return on Assets (%)	8.99	7.88	13.05	7.5	4.58	5.33	5.68	5.82	6.37	4.54	6.19	4.34	6	7.21	8.31
Return on Capital (%)	15.75	10.29	17.71	9.61	5.87	7.13	7.27	7.53	8.29	6.36	7.67	5.83	7.01	7.87	8.16
Return on Invested Capital (%)	17.68	14.79	22.95	13.08	9.72	10.5	11.05	11.29	11.31	7.65	9.2	9.11	11.35	12.8	14.54
Gross Margin (%)	94.88	46.01	46.82	46.36	42.24	41.64	41.14	41.25	40.48	95.21	95.41	40.32	41.3	41.56	95.71
EBITDA Margin (%)	21.26	23.2	25.57	23.67	21.31	22.35	21.01	19.39	19.62	20.42	21.87	20.06	20.95	21.65	23.27
Operating Margin (%)	18.65	19.36	20.42	19.61	17.79	17.81	16.59	15.94	15.04	14.87	16.42	14.49	15.24	16.09	17.74
Incremental Operating Margin (%)	32	30.47	40.43	5.43	11.94	17.95	0.22	8.86	3.33	15.61	28.76	- -	22.45	23.2	33.56
Pretax Margin (%)	12.11	15.93	17.59	16.3	12.7	13.23	12.68	11.53	12.21	9.9	12.58	10.37	12.65	13.95	16.06
Profit Margin (%)	10.4	8.67	14.4	9.35	5.88	6.8	6.93	6.83	7.79	7.97	10.27	6.23	7.33	8.48	9.54
Net Income to Common Margin (%)	9.11	7.55	13.47	9.08	5.83	6.8	6.93	6.83	7.79	7.97	10.27	6.23	7.33	8.48	9.54
Effective Tax Rate (%)	15.27	31.94	3.21	28.61	35.87	34	29.37	24.11	20.61	21.17	20.18	22.2	21.77	20.04	20.24
Dvd Payout Ratio (%)	- -	0.27	4.22	19.96	23.49	21.56	21.29	22.04	20.37	30.82	22.08	22.22	10.31	8.48	7.46
Sustainable Growth Rate (%)	- -	78.76	91.2	42.22	25.61	28.83	22.6	18.76	21.73	13.37	18.36	13.09	21.35	22.45	23.26

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	1,255	1,254	1,518	2,111	3,172	3,016	2,578	2,514	3,347	3,543	3,481	2,992	2,933	2,714	2,714
ST Debt	19	14	12	21	37	37	32	36	80	83	61	51	49	165	70
LT Debt	1,236	1,240	1,505	2,090	3,135	2,979	2,545	2,479	3,267	3,460	3,420	2,942	2,884	2,549	2,644
Total Debt/EBITDA	2.94	2.53	2.64	3.76	4.78	3.71	3.13	3.03	3.7	4.87	3.97	3.43	2.92	2.33	1.97
Net Debt/EBITDA	2.87	2.26	2.53	3.64	4.68	3.66	3.07	2.95	3.28	4.21	3.68	3.15	2.63	2.07	1.75
Total Debt/EBIT	3.61	3.04	3.16	4.65	6.05	4.7	4.04	3.99	4.89	6.75	5.29	4.76	4.01	3.14	2.58
Net Debt/EBIT	3.52	2.71	3.03	4.5	5.93	4.64	3.95	3.88	4.33	5.83	4.9	4.37	3.61	2.79	2.3
EBITDA to Interest Expense	3.57	5.26	5.72	5.15	4.65	4.73	5.33	5.63	5.66	3.96	5.34	4.97	7.01	8.47	11.21
EBITDA-CapEx/Interest Expense	2.66	3.57	3.57	3.42	3.55	3.55	3.84	3.86	3.21	1.81	1.98	1.58	2.94	3.79	5.23
EBIT to Interest Expense	3.13	4.39	4.57	4.26	3.88	3.77	4.21	4.63	4.34	2.89	4.01	3.59	5.1	6.29	8.55
Interest Expense	119	94	100	109	143	172	154	147	160	184	164	176	144	137	123
Common Equity/Total Assets	5.15	12	13.6	13.97	13.27	15.72	23.69	24.67	22.24	24.64	27.84	23.25	27	31.63	34.39
Long-Term Debt/Equity (%)	209.81	164.68	261.59	262.15	348.15	279.22	157.48	136.28	169.04	172.87	142.55	157.98	125.54	89.46	80.71
Long-Term Debt/Capital (%)	67.03	61.8	71.92	71.87	76.98	72.96	60.69	57.2	61.88	62.4	58.16	60.6	55.14	45.82	44.14
Long-Term Debt/Total Assets (%)	54.41	51.15	59.39	61.69	68.06	63.63	52.33	47.9	53.73	53.68	49.82	52.19	47.26	39.01	37.29
Total Debt/Equity (%)	213.02	166.49	263.73	264.76	352.23	282.7	159.48	138.25	173.17	177.02	145.11	160.71	127.67	95.25	82.85
Total Debt/Capital (%)	68.05	62.48	72.51	72.58	77.89	73.87	61.46	58.03	63.39	63.9	59.2	61.64	56.08	48.78	45.31
Total Debt/Total Assets (%)	55.24	51.71	59.88	62.31	68.85	64.43	52.99	48.59	55.04	54.97	50.71	53.09	48.06	41.53	38.28
Net Debt to Equity	207.91	148.85	252.52	256.4	345.39	278.9	156.12	134.45	153.56	153.12	134.58	147.44	115.07	84.67	73.83
Net Debt/Capital (%)	67.52	59.82	71.63	71.94	77.55	73.61	60.96	57.35	57.24	57.6	55.37	56.81	51.22	44.04	40.87
EBITDA	426	495	575	562	664	814	823	829	904	728	878	872	1,006	1,164	1,381
EBITDA-CapEx	317	336	358	374	508	611	593	569	512	332	326	278	423	521	645
Operating Income (Loss)	374	413	459	466	554	649	649	682	693	530	659	630	732	865	1,053

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.14	0.44	0.21	0.18	0.14	0.09	0.11	0.1	0.13	0.31	0.07	0.04	0.11	0.1	0.09
Current Ratio	1.57	2.12	1.86	1.88	1.4	1.38	1.36	0.98	1.05	1.32	1.23	1.25	1.28	1.05	1.08
Quick Ratio	0.86	1.27	1.05	1.07	1.11	1.02	1.02	0.8	0.83	1.11	0.75	0.97	1.04	0.81	0.83
CFO/Avg Current Liab	1.02	1.34	1.54	1.32	1.27	1.42	1.33	1.28	0.91	0.98	0.98	1.07	1.38	1.34	1.4
Common Equity/Total Assets	5.15	12	13.6	13.97	13.27	15.72	23.69	24.67	22.24	24.64	27.84	23.25	27	31.63	34.39
Long-Term Debt/Equity (%)	209.81	164.68	261.59	262.15	348.15	279.22	157.48	136.28	169.04	172.87	142.55	157.98	125.54	89.46	80.71
Long-Term Debt/Capital (%)	67.03	61.8	71.92	71.87	76.98	72.96	60.69	57.2	61.88	62.4	58.16	60.6	55.14	45.82	44.14
Long-Term Debt/Total Assets (%)	54.41	51.15	59.39	61.69	68.06	63.63	52.33	47.9	53.73	53.68	49.82	52.19	47.26	39.01	37.29
Total Debt/Equity (%)	213.02	166.49	263.73	264.76	352.23	282.7	159.48	138.25	173.17	177.02	145.11	160.71	127.67	95.25	82.85
Total Debt/Capital (%)	68.05	62.48	72.51	72.58	77.89	73.87	61.46	58.03	63.39	63.9	59.2	61.64	56.08	48.78	45.31
Total Debt/Total Assets (%)	55.24	51.71	59.88	62.31	68.85	64.43	52.99	48.59	55.04	54.97	50.71	53.09	48.06	41.53	38.28
CFO/Total Liabilities	20.37	24.62	24.01	17.17	13.55	17.71	20.27	22.72	15.32	15.86	16.03	18.7	22.36	27.21	30.82
CFO/CapEx	3.14	2.58	2.17	2.37	3.21	3.16	2.87	2.93	1.62	1.78	1.3	1.19	1.46	1.56	1.6
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.4	3.74

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	8.96	9.04	8.79	8.12	8.49	8.53	8.55	9.1	9.46	6.61	7.38	8.26	8.36	8.88	9.75
Days Sales Outstanding	40.73	40.36	41.51	44.97	42.98	42.8	42.71	40.1	38.59	55.21	49.48	44.18	43.65	41.11	37.45
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,232	10,633
- Cash & Cash Equivalents	30	133	65	67	62	41	54	69	95	224	49	22	69	85	72
+ Preferred Equity and Hybrid Capital	387	342	93	93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	85	120	138	231	289	331	464	542	581	414	488	552	650	782	838
+ Total Debt	1,255	1,254	1,518	2,111	3,172	3,016	2,578	2,514	3,347	3,543	3,481	2,992	2,933	2,714	2,714
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12,643	14,112
Total Capital	1,844	2,006	2,093	2,909	4,072	4,083	4,194	4,333	5,280	5,545	5,881	4,854	5,230	5,563	5,990
Total Debt/Capital (%)	68.05	62.48	72.51	72.58	77.89	73.87	61.46	58.03	63.39	63.9	59.2	61.64	56.08	48.78	45.31
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.21	0.19
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.35	2.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.87	10.22
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.63	13.4
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.36	11.08
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	26.89	26.26
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9,362	10,867
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12,773	14,347
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	125.45	141.13
TTM Sales	2,006	2,135	2,247	2,374	3,116	3,643	3,914	4,277	4,605	3,566	4,015	4,349	4,801	5,373	5,935
TTM EBITDA	426	495	575	562	664	814	823	829	904	728	878	872	1,006	1,164	1,381
TTM Operating Income	374	413	459	466	554	649	649	682	693	530	659	630	732	865	1,053
TTM Cash Flow to Firm	444	476	567	523	594	754	767	874	762	850	847	842	963	1,113	1,274
TTM Free Cash Flow to Firm	335	316	351	335	437	551	538	614	371	453	295	248	380	470	537

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.99	24.74
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.63	13.4
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12,643	14,112
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	77.28	88.95
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.35	2.38
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.87	10.22
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	20.08	18.87
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.7	19.64
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	22.66	22.34
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.94	15.79
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.47	4.36
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4.38	4.54
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.04	5.16
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.77	3.65
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.07	13.09
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18.7	13.62
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.52	15.5
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.08	10.95
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.7	1.8
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.67	1.87
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.92	2.13
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.44	1.51
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.13	9.09
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	8.95	9.46
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.3	10.76
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.7	7.6
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	25.49	25.75
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	29.32	29.29
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.92	20.7
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.32	2.45
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.57	2.71
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.08	2.08
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	10.72	10.53
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.89	11.63
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.62	8.96
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.43	13.81
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16.01	15.26
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.96	11.75
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	91.61	106.33
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	103.38	125.87
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12,467	14,543
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13,829	16,066
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	11,198	12,374

Shares Outstanding	95	96	88	88	90	89	98	99	99	99	99	100	100	101	100
Diluted Weighted Avg Shares	109	108	102	101	101	100	99	100	99	100	100	100	101	102	102
Basic Weighted Avg Shares	93	95	88	87	89	89	94	98	98	99	99	99	100	100	101
Revenue per Share	21.5	22.57	25.51	27.35	34.85	40.88	41.77	43.69	46.99	36.17	40.55	43.84	48.25	53.79	59.06
EBITDA per Share	4.57	5.24	6.52	6.47	7.43	9.14	8.78	8.47	9.22	7.39	8.87	8.79	10.11	11.65	13.74
Operating Income per Share	4.01	4.37	5.21	5.37	6.2	7.28	6.93	6.96	7.07	5.38	6.66	6.35	7.35	8.65	10.48
Basic EPS, GAAP	1.96	1.7	3.43	2.49	2.03	2.78	2.89	2.99	3.66	2.88	4.16	2.73	3.54	4.56	5.63
Basic EPS from Cont Ops	2.21	2.45	4.34	3.18	2.84	3.57	3.74	3.82	4.56	2.82	4.07	3.54	4.77	6	7.56
Diluted EPS, GAAP	1.67	1.49	2.96	2.14	1.8	2.49	2.73	2.93	3.61	2.85	4.11	2.7	3.47	4.46	5.54
Diluted EPS from Cont Ops	1.88	2.14	3.75	2.74	2.51	3.2	3.53	3.75	4.49	2.79	4.02	3.49	4.69	5.86	7.44
Dividend per Share	0.28	0.26	0.44	0.83	0.86	0.94	0.98	1.03	1.11	1.13	1.13	1	0.61	0.63	0.71
Cash Flow per Share	3.67	4.35	5.34	5.13	5.62	7.19	7.03	7.79	6.48	7.15	7.23	7.11	8.55	10.04	11.7
Free Cash Flow per Basic Share	2.5	2.66	2.88	2.96	3.86	4.91	4.58	5.13	2.49	3.13	1.65	1.13	2.69	3.61	4.37
Cash & Equivalents per Share	0.47	1.39	0.73	0.76	0.68	0.46	0.55	0.7	0.96	2.25	0.5	0.22	0.69	0.85	0.72
Book Value per Share	1.23	3.04	3.92	5.39	6.78	8.28	11.72	12.91	13.71	15.97	19.21	13.13	16.43	20.51	24.38
Tangible Book Value per Share	-3.8	-2.29	-2.28	-10.44	-18.84	-18.02	-12.44	-12.81	-14.5	-11.69	5.19	-2.36	0.88	4.8	8.12

Encompass Health Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)